In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Practice Guideline Track on Non-ST Elevation Acute Coronary Syndromes

Guidelines into Practice

Acute Coronary Syndromes (ACS)
Cardiovascular Pharmacology and Pharmacotherapy


Contributors:  Special thanks to Baris Gencer from the ESC Working Groups on Cardiovascular Pharmacotherapy, Cardiovascular Surgery, Coronary Pathophysiology and Microcirculation, Thrombosis.

Based on the 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Webinars on this topic

 ESC webinar on "Non-ST elevation acute coronary syndromes : what is new in the 2015 ESC Guidelines?"  streamed live on 14 December 2015 Watch the recording. 

 

Part 1 - Overview of the ESC 2015 Guidelines on NSTE-ACS

 

Session Title Slides Webcast

ESC congress highlights- Acute coronary syndromes and acute cardiac care

   

Meet the Task Force II

   

Meet the Task Force II - panel discussion

   

Antithrombotic treatment

   
Diagnostic and risk assessment    
Invasive strategies and revascularization     
Special populations and conditions    
What do the guidelines say?    

 

Part 2 - Topics in focus

Session Title Slides Webcast
Challenges in troponin interpretation    
Acute pulmonary oedema and atrial fibrillation with elevated troponin.    
Acute pulmonary oedema and atrial fibrillation with elevated troponin - Panel discussion and questions from the audience.    
Positive troponin after cardiac surgery - Panel discussion and questions from the audience.    
Positive troponin after cardiac surgery.    
Challenges in troponin interpretation. State of the Art lecture     
Advances in Science - Post infarction period    
State of the Art in risk assessment of patients post myocardial infarction.    
Chronology of events after hospital discharge following acute myocardial infarction is not uniform. Five-year follow-up of the FAST-MI 2005 registry

   
Long term relative survival and excess mortality after acute myocardial infarction, 2003-2010: a national cohort study

   
Optimising management of ACS in different patient subgroups     
Elderly      
Women    
Diabetics    
Atrial Fibrillation patients.    
Meet the experts
   
Difficult cases in acute coronary syndromes revascularisation in clinical practice - Introduction to the session.    
NSTEMI case with three vessel disease.

   
NSTEMI case with three vessel disease - Panel discussion and questions from the audience.    
STEMI case with three vessel disease.    
STEMI case with three vessel disease - Panel discussion and questions from the audience.    
Guidelines in Daily Practice
   
What do the new ESC guidelines tell us in Germany - case presentation    
Acute coronary syndromes NSTEMI in Germany:  What do the "new" 2015 Guidelines tell us?    
What do the new ESC guidelines tell us in Serbia -case presentation    
Acute coronary syndromes NSTEMI in Serbia:  What do the "new" 2015 Guidelines tell us?    
NSTEMI guidelines: helpful in real world?   NSTEMi and Afib    
NSTEMI and atrial fibrillation     
NSTEMI and atrial fibrillation - What do the Guidelines say?    
NSTEMI and atrial fibrillation - Panel discussion on how to implement the Guidelines    
NSTEMI and atrial fibrillation - Conclusion and take home message.    
NSTEMI guidelines: helpful in real world?  Pre treatment in NSTEMI    
Pre treatment in NSTEMI    
Pre treatment in NSTEMI - What do the Guidelines say?    
Pre treatment in NSTEMI - Panel discussion on how to implement the Guidelines    
Pre treatment in NSTEMI - Conclusion and take home message.